Angiodynamics (ANGO) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Angiodynamics (ANGO) over the last 17 years, with Q1 2025 value amounting to $0.03.
- Angiodynamics' Debt to Equity fell 3807.27% to $0.03 in Q1 2025 from the same period last year, while for Feb 2025 it was $0.03, marking a year-over-year decrease of 3807.27%. This contributed to the annual value of $0.02 for FY2024, which is 8652.82% down from last year.
- Latest data reveals that Angiodynamics reported Debt to Equity of $0.03 as of Q1 2025, which was down 3807.27% from $0.03 recorded in Q4 2024.
- In the past 5 years, Angiodynamics' Debt to Equity registered a high of $0.17 during Q2 2023, and its lowest value of $0.01 during Q3 2023.
- For the 5-year period, Angiodynamics' Debt to Equity averaged around $0.07, with its median value being $0.06 (2021).
- In the last 5 years, Angiodynamics' Debt to Equity skyrocketed by 16432.54% in 2021 and then crashed by 9220.16% in 2023.
- Angiodynamics' Debt to Equity (Quarter) stood at $0.06 in 2021, then soared by 152.48% to $0.15 in 2022, then crashed by 83.97% to $0.02 in 2023, then grew by 13.51% to $0.03 in 2024, then grew by 1.29% to $0.03 in 2025.
- Its Debt to Equity was $0.03 in Q1 2025, compared to $0.03 in Q4 2024 and $0.02 in Q3 2024.